FDA Handling Of Antidepressant Inquiry “Troubles” Senate Investigators
This article was originally published in The Pink Sheet Daily
Executive Summary
Finance Committee staff continues its inquiry into how FDA handled information on a possible link between antidepressants and suicidality. A June 2 letter asks for contact information of former Office of Drug Safety employees and a list of meetings between CDER officials and manufacturers.